CIAM
BMY icon

Caitong International Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Caitong International Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,006
Closed -$432K – 2636
2025
Q4 		$432K Sell
8,006
-1,474
-16% -$70.9K 0.11% 100
2025
Q3 		$428K Buy
9,480
+3,420
+56% +$160K 0.3% 37
2025
Q2 		$281K Buy
6,060
+6,027
+18,264% +$296K 0.2% 59
2025
Q1 		$2.01K Sell
33
-391
-92% -$22.8K ﹤0.01% 1339
2024
Q4 		$24K Buy
+424
New +$23.7K 0.02% 736

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Caitong International Asset Management's BMY Position: Q1 2026 in Review

Caitong International Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 8,006 shares — an estimated $432K sold.

Caitong International Asset Management first reported a position in BMY in Q4 2024 and held it in 5 quarters. The position peaked at $432K in Q4 2025. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Caitong International Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 8,006 Bristol-Myers Squibb shares in Q1 2026, an estimated $432K.
  • Caitong International Asset Management first reported a position in Bristol-Myers Squibb in Q4 2024 and held it in 5 quarters.
  • Caitong International Asset Management's Bristol-Myers Squibb position peaked at $432K in Q4 2025.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.